PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRAX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/20	21 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/05/13	21 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/05/13	21 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/04/12	21 : 00	GlobeNewswire Inc.	Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/03/05	23 : 08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/03/05	21 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/03/05	21 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/03/05	21 : 12	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/15	10 : 45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/15	06 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/15	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/15	00 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/14	09 : 08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/02/01	06 : 20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/18	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/18	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/18	06 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/18	06 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/13	07 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/13	07 : 20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/11	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/11	07 : 28	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/11	06 : 19	GlobeNewswire Inc.	Praxis Precision Medicines, Inc. Announces Proposed Public Offering	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/11	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/10	11 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/10	11 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/10	11 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2024/01/10	11 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
2023/12/08	07 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
2023/12/08	07 : 19	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRAX	Praxis Precision Medicines Inc